Orchestra BioMed Holdings (OBIO) Inventory Average (2023 - 2026)
Orchestra BioMed Holdings (OBIO) reported Inventory Average of $293500.0 for Q1 2026, up 90.58% year-over-year from $154000.0 in Q1 2025, and down 13.04% on a QoQ basis from $337500.0 in Q4 2025.
Orchestra BioMed Holdings (OBIO) has 4 years of Inventory Average data on file, last reported at $293500.0 in Q1 2026.
- Quarterly Inventory Average rose 90.58% year-over-year to $293500.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $293500.0 (up 90.58% YoY) and the FY2025 annual result came in at $241500.0, up 51.41% from the prior year.
- Inventory Average fell to $293500.0 in Q1 2026 per OBIO's latest filing, from $337500.0 in the prior quarter.
- Across five years, Inventory Average topped out at $337500.0 in Q4 2025 and bottomed at $92500.0 in Q2 2024.
- The 4-year median for Inventory Average is $160000.0 (2025), against an average of $196653.8.
- The widest annual swing landed in 2024, when Inventory Average slumped 54.88%; it then soared 90.58% in 2026.
- Tracing OBIO's Inventory Average over 4 years: stood at $141500.0 in 2023, then soared by 43.82% to $203500.0 in 2024, then jumped by 65.85% to $337500.0 in 2025, then decreased by 13.04% to $293500.0 in 2026.
- Per Business Quant, the three latest OBIO Inventory Average figures stand at $293500.0 (Q1 2026), $337500.0 (Q4 2025), and $275000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.15 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 83.37 Mn |
| 10 | Orchestra BioMed Holdings | 245.24 Mn | 255.02 Mn | 78,000.00 | 293,500.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 293,500.00 |
| Dec 31, 2025 | 337,500.00 |
| Sep 30, 2025 | 275,000.00 |
| Jun 30, 2025 | 160,000.00 |
| Mar 31, 2025 | 154,000.00 |
| Dec 31, 2024 | 203,500.00 |
| Sep 30, 2024 | 152,000.00 |
| Jun 30, 2024 | 92,500.00 |
| Mar 31, 2024 | 130,500.00 |
| Dec 31, 2023 | 141,500.00 |
| Sep 30, 2023 | 157,500.00 |
| Jun 30, 2023 | 205,000.00 |
| Mar 31, 2023 | 254,000.00 |